In hepatocellular cancer cell lines (HepG2, Bel-7402, SMMC-7721), RES activated SIRT1 protein and inhibited SIRT1-mediated post-translational modification of PI3K/AKT signaling [91]. Here, SIRT1 is linked to hepatocellular carcinoma.